Education
About Us
Working with TipRanks
Follow Us
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Total Valuation
Exact Sciences has a market cap or net worth of $8.73B. The enterprise value is $11.72B.
Market Cap$8.73B
Enterprise Value$11.72B
Share Statistics
Exact Sciences has 189,319,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding189,319,100
Owned by Insiders1.05%
Owned by Institutions29.48%
Financial Efficiency
Exact Sciences’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -19.03%.
Return on Equity (ROE)-0.43
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-19.03%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee399.84K
Profits Per Employee-149.11K
Employee Count6,900
Asset Turnover0.47
Inventory Turnover5.17
Valuation Ratios
The current PE Ratio of Exact Sciences is ―. Exact Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value4.31
Price to FCF―
Price to Operating Cash Flow28.50
PEG Ratio―
Income Statement
In the last 12 months, Exact Sciences had revenue of 2.76B and earned -1.03B in profits. Earnings per share was -5.59.
Revenue2.76B
Gross Profit1.92B
Operating Income-1.05B
Pretax Income-1.04B
Net Income-1.03B
EBITDA-788.73M
Earnings Per Share (EPS)-5.59
Cash Flow
In the last 12 months, operating cash flow was 305.61M and capital expenditures -135.99M, giving a free cash flow of 169.62M billion.
Operating Cash Flow305.61M
Free Cash Flow169.62M
Free Cash Flow per Share0.90
Dividends & Yields
Exact Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-23.61%
50-Day Moving Average49.18
200-Day Moving Average51.47
Relative Strength Index (RSI)49.62
Average Volume (3m)3.38M
Important Dates
Exact Sciences upcoming earnings date is Oct 29, 2025, After Close (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend Date―
Financial Position
Exact Sciences as a current ratio of 2.15, with Debt / Equity ratio of 102.11%
Current Ratio2.15
Quick Ratio1.92
Debt to Market Cap0.25
Net Debt to EBITDA-2.73
Interest Coverage Ratio-32.80
Taxes
In the past 12 months, Exact Sciences has paid -7.30M in taxes.
Income Tax-7.30M
Effective Tax Rate<0.01
Enterprise Valuation
Exact Sciences EV to EBITDA ratio is -15.85, with an EV/FCF ratio of 167.73.
EV to Sales4.53
EV to EBITDA-15.85
EV to Free Cash Flow167.73
EV to Operating Cash Flow59.39
Balance Sheet
Exact Sciences has $858.43M in cash and marketable securities with $2.52B in debt, giving a net cash position of $1.66B billion.
Cash & Marketable Securities$858.43M
Total Debt$2.52B
Net Cash$1.66B
Net Cash Per Share$8.78
Tangible Book Value Per Share-$5.29
Margins
Gross margin is 68.19%, with operating margin of -38.01%, and net profit margin of -37.29%.
Gross Margin68.19%
Operating Margin-38.01%
Pretax Margin-37.56%
Net Profit Margin-37.29%
EBITDA Margin-28.59%
EBIT Margin-36.40%
Analyst Forecast
The average price target for Exact Sciences is $62.53, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$62.53
Price Target Upside33.87% Upside
Analyst ConsensusStrong Buy
Analyst Count20
Revenue Growth Forecast12.56%
EPS Growth Forecast-464.28%